Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Corpora amylacea act as containers that remove waste products from the brain.

Riba M, Augé E, Campo-Sabariz J, Moral-Anter D, Molina-Porcel L, Ximelis T, Ferrer R, Martín-Venegas R, Pelegrí C, Vilaplana J.

Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):26038-26048. doi: 10.1073/pnas.1913741116. Epub 2019 Dec 3.

2.

Teaching case 3-2019: Are nuclear clefts or invaginations the niche of intranuclear inclusions in FTLD-TDP?

Molina-Porcel L, Pérez-Navarro E, García-Forn M, Westaway D, Colom-Cadena M, Gelpi E.

Clin Neuropathol. 2019 May/Jun;38(3):97-99. doi: 10.5414/NP301202. No abstract available.

3.

Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.

Borrego-Écija S, Cortés-Vicente E, Cervera-Carles L, Clarimón J, Gámez J, Batlle J, Ricken G, Molina-Porcel L, Aldecoa I, Sánchez-Valle R, Rojas-García R, Gelpi E.

Neuropathol Appl Neurobiol. 2019 Jun;45(4):421-426. doi: 10.1111/nan.12527. Epub 2018 Nov 20. No abstract available.

PMID:
30375034
4.

Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias.

Fournier C, Anquetil V, Camuzat A, Stirati-Buron S, Sazdovitch V, Molina-Porcel L, Turbant S, Rinaldi D, Sánchez-Valle R, Barbier M, Latouche M; Neuro-CEB Neuropathology Network, Stevanin G, Seilhean D, Brice A, Duyckaerts C, Le Ber I.

Acta Neuropathol Commun. 2018 May 30;6(1):41. doi: 10.1186/s40478-018-0547-8. No abstract available.

5.

Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.

Robinson JL, Molina-Porcel L, Corrada MM, Raible K, Lee EB, Lee VM, Kawas CH, Trojanowski JQ.

Brain. 2014 Sep;137(Pt 9):2578-87. doi: 10.1093/brain/awu190. Epub 2014 Jul 9.

6.

Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.

Hurtado DE, Molina-Porcel L, Carroll JC, Macdonald C, Aboagye AK, Trojanowski JQ, Lee VM.

J Neurosci. 2012 May 23;32(21):7392-402. doi: 10.1523/JNEUROSCI.0889-12.2012.

7.

Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.

Brettschneider J, Van Deerlin VM, Robinson JL, Kwong L, Lee EB, Ali YO, Safren N, Monteiro MJ, Toledo JB, Elman L, McCluskey L, Irwin DJ, Grossman M, Molina-Porcel L, Lee VM, Trojanowski JQ.

Acta Neuropathol. 2012 Jun;123(6):825-39. doi: 10.1007/s00401-012-0970-z. Epub 2012 Mar 18.

8.

TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation.

Martinez-Lage M, Molina-Porcel L, Falcone D, McCluskey L, Lee VM, Van Deerlin VM, Trojanowski JQ.

Acta Neuropathol. 2012 Aug;124(2):285-91.

9.

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes.

Setó-Salvia N, Clarimón J, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Combarros O, Mateo JI, Regaña D, Martínez-Corral M, Marquié M, Alcolea D, Suárez-Calvet M, Molina-Porcel L, Dols O, Gómez-Isla T, Blesa R, Lleó A, Kulisevsky J.

Arch Neurol. 2011 Mar;68(3):359-64. doi: 10.1001/archneurol.2011.17.

PMID:
21403021
10.

IGF-I gene variability is associated with an increased risk for AD.

Vargas T, Martinez-Garcia A, Antequera D, Vilella E, Clarimon J, Mateo I, Sanchez-Juan P, Rodriguez-Rodriguez E, Frank A, Rosich-Estrago M, Lleo A, Molina-Porcel L, Blesa R, Gomez-Isla T, Combarros O, Bermejo-Pareja F, Valdivieso F, Bullido MJ, Carro E.

Neurobiol Aging. 2011 Mar;32(3):556.e3-11. doi: 10.1016/j.neurobiolaging.2010.10.017. Epub 2010 Dec 22.

PMID:
21176999
11.

[(123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia].

Marquié Sayagués M, Da Silva Alves L, Molina-Porcel L, Alcolea Rodríguez D, Sala Matavera I, Sánchez-Saudinós MB, Camacho Martí V, Estorch Cabrera M, Blesa González R, Blesa González R, Gómez-Isla T, Gómez-Isla T, Lleó Bisa A, Lleó Bisa A.

Neurologia. 2010 Sep;25(7):414-21. Spanish.

12.

A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.

Hurtado DE, Molina-Porcel L, Iba M, Aboagye AK, Paul SM, Trojanowski JQ, Lee VM.

Am J Pathol. 2010 Oct;177(4):1977-88. doi: 10.2353/ajpath.2010.100346. Epub 2010 Aug 27.

13.

A megalin polymorphism associated with promoter activity and Alzheimer's disease risk.

Vargas T, Bullido MJ, Martinez-Garcia A, Antequera D, Clarimon J, Rosich-Estrago M, Martin-Requero A, Mateo I, Rodriguez-Rodriguez E, Vilella-Cuadrada E, Frank A, Lleo A, Molina-Porcel L, Blesa R, Combarros O, Gomez-Isla T, Bermejo-Pareja F, Valdivieso F, Carro E.

Am J Med Genet B Neuropsychiatr Genet. 2010 Jun 5;153B(4):895-902. doi: 10.1002/ajmg.b.31056.

PMID:
20052685
14.

Mild cholesterol depletion reduces amyloid-beta production by impairing APP trafficking to the cell surface.

Guardia-Laguarta C, Coma M, Pera M, Clarimón J, Sereno L, Agulló JM, Molina-Porcel L, Gallardo E, Deng A, Berezovska O, Hyman BT, Blesa R, Gómez-Isla T, Lleó A.

J Neurochem. 2009 Jul;110(1):220-30. doi: 10.1111/j.1471-4159.2009.06126.x. Epub 2009 Apr 27.

15.

Early-onset familial lewy body dementia with extensive tauopathy: a clinical, genetic, and neuropathological study.

Clarimón J, Molina-Porcel L, Gómez-Isla T, Blesa R, Guardia-Laguarta C, González-Neira A, Estorch M, Ma Grau J, Barraquer L, Roig C, Ferrer I, Lleó A.

J Neuropathol Exp Neurol. 2009 Jan;68(1):73-82. doi: 10.1097/NEN.0b013e3181927577.

PMID:
19104444
16.

Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance.

Sala I, Belén Sánchez-Saudinós M, Molina-Porcel L, Lázaro E, Gich I, Clarimón J, Blanco-Vaca F, Blesa R, Gómez-Isla T, Lleó A.

Dement Geriatr Cogn Disord. 2008;26(6):506-12. doi: 10.1159/000173710. Epub 2008 Nov 20.

PMID:
19023204
17.

Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP.

Guerreiro RJ, Baquero M, Blesa R, Boada M, Brás JM, Bullido MJ, Calado A, Crook R, Ferreira C, Frank A, Gómez-Isla T, Hernández I, Lleó A, Machado A, Martínez-Lage P, Masdeu J, Molina-Porcel L, Molinuevo JL, Pastor P, Pérez-Tur J, Relvas R, Oliveira CR, Ribeiro MH, Rogaeva E, Sa A, Samaranch L, Sánchez-Valle R, Santana I, Tàrraga L, Valdivieso F, Singleton A, Hardy J, Clarimón J.

Neurobiol Aging. 2010 May;31(5):725-31. doi: 10.1016/j.neurobiolaging.2008.06.012. Epub 2008 Jul 30.

18.

Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease.

Molina-Porcel L, Lladó A, Rey MJ, Molinuevo JL, Martinez-Lage M, Esteve FX, Ferrer I, Tolosa E, Blesa R.

Arch Neurol. 2008 Feb;65(2):272-5. doi: 10.1001/archneurol.2007.37.

PMID:
18268200
19.

Does thrombolysis benefit patients with lacunar syndrome?

Cocho D, Belvís R, Martí-Fàbregas J, Bravo Y, Aleu A, Pagonabarraga J, Molina-Porcel L, Díaz-Manera J, San Roman L, Martínez-Lage M, Martínez A, Moreno M, Martí-Vilalta JL.

Eur Neurol. 2006;55(2):70-3. Epub 2006 Mar 10.

PMID:
16534209
20.

Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.

Cocho D, Borrell M, Martí-Fàbregas J, Montaner J, Castellanos M, Bravo Y, Molina-Porcel L, Belvís R, Díaz-Manera JA, Martínez-Domeño A, Martínez-Lage M, Millán M, Fontcuberta J, Martí-Vilalta JL.

Stroke. 2006 Apr;37(4):996-9. Epub 2006 Feb 23.

PMID:
16497981
21.

Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA.

Martí-Fàbregas J, Borrell M, Cocho D, Belvís R, Castellanos M, Montaner J, Pagonabarraga J, Aleu A, Molina-Porcel L, Díaz-Manera J, Bravo Y, Alvarez-Sabín J, Dávalos A, Fontcuberta J, Martí-Vilalta JL.

Neurology. 2005 Aug 9;65(3):366-70.

PMID:
16087899
22.

["Seronegative" myasthenia gravis and antiMuSK positive antibodies: description of Spanish series].

Illa I, Díaz-Manera JA, Juárez C, Rojas-García R, Molina-Porcel L, Aleu A, Pradas J, Gallardo E.

Med Clin (Barc). 2005 Jun 18;125(3):100-2. Spanish.

PMID:
15989843
23.

Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.

Cocho D, Belvís R, Martí-Fàbregas J, Molina-Porcel L, Díaz-Manera J, Aleu A, Pagonabarraga J, García-Bargo D, Mauri A, Martí-Vilalta JL.

Neurology. 2005 Feb 22;64(4):719-20.

PMID:
15728300
24.

Favorable outcome of ischemic stroke in patients pretreated with statins.

Martí-Fàbregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvís R, Cocho D, Roquer J, Rodríguez A, García MD, Molina-Porcel L, Díaz-Manera J, Martí-Vilalta JL.

Stroke. 2004 May;35(5):1117-21. Epub 2004 Apr 8.

PMID:
15073403

Supplemental Content

Loading ...
Support Center